BWL Investments Ltd.
Known title: 10% OwnerCIK: 0002003791
Associated companies
Transaction History
| ELAB | ▼ Sell | Other | 828,000 | $0 | 12/28/2023 | View on chart |
| ELAB | ▼ Sell | Other | 828,000 | $0 | 12/28/2023 | View on chart |
| ELAB | ▼ Sell | Other | 828,000 | $0 | 12/28/2023 | View on chart |
| ELAB | ▼ Sell | Other | 828,000 | $0 | 12/28/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
PMGC Holdings Completes $100M SPAC IPO, Launches NorthStrive
PMGC Holdings has completed a $100 million SPAC IPO, launching NorthStrive Acquisition Corp. I as the first in a planned series to expand its M&A strategy. Additionally, its subsidiary NorthStrive Biosciences has partnered with Charles River Laboratories to conduct analytical characterization for its EL-22 and EL-32 engineered probiotic programs. These moves signal a shift toward corporate expansion and advanced development partnerships for the company.
PMGC Holdings Completes $100M SPAC IPO, Launches NorthStrive. PMGC Holdings has completed a $100 million SPAC IPO, launching NorthStrive Acquisition Corp. I as the first in a planned series to expand its M&A strategy. Additionally, its subsidiary NorthStrive Biosciences has partnered with Charles River Laboratories to conduct analytical characterization for its EL-22 and EL-32 engineered probiotic programs. These moves signal a shift toward corporate expansion and advanced development partnerships for the company.